News
This downturn is primarily attributed to a continued increase in medical costs for government-backed insurance plans, ...
The U.S. insurance operations of the company will continue to be a significant contributor to earnings for this quarter.
Recently, analysts at EPFR, an ISI Markets company, caused a bit of a stir by publishing the chart above. It shows that ...
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the ...
FedEx's restructuring and AI investments show potential, but execution risks and competition loom. Learn why a Hold rating ...
John B. MacIntyre, retired partner-emeritus of Birch Hill Capital Partners, will succeed Alan MacGibbon as chair of TD Bank ...
UnitedHealth Group Incorporated (NYSE:UNH) ranks among the best low volatility stocks to buy according to analysts. On July ...
NEW YORK, July 28, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from ...
On July 21, CNBC reported that gold prices rose around 25% this year amid a backdrop where investors are continually looking ...
Safe Bulkers, Inc. (the Company) (NYSE: SB), an international provider of marine drybulk transportation services, announced ...
McEwen (NYSE:MUX) said Monday it agreed to acquire Canadian Gold Corp. (OTCQB:STRRF) in an all-stock deal valuing each Canadian Gold share at C$0.35, a 26% premium to its 30-day average. Under the ...
1h
24/7 Wall St. on MSN4 High-Yield Blue-Chip Pharmaceutical Giants Offer Huge Total Return PotentialHere are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results